Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/23904
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bazban-Shotorbani, S | - |
dc.contributor.author | Gavins, F | - |
dc.contributor.author | Kant, K | - |
dc.contributor.author | Dufva, M | - |
dc.contributor.author | Kamaly, N | - |
dc.date.accessioned | 2022-01-08T10:09:29Z | - |
dc.date.available | 2022-01-08T10:09:29Z | - |
dc.date.issued | 2022-01-05 | - |
dc.identifier | 202270011 | - |
dc.identifier.citation | Bazban-Shotorbani, S., Gavins, F., Kant, K., Dufva, M. and Kamaly, N. (2022) 'A Biomicrofluidic Screening Platform for Dysfunctional Endothelium-Targeted Nanoparticles and Therapeutics', Advanced NanoBiomed Research, 2, 2270011, pp. 1-1 [cover picture]. doi: 10.1002/anbr.202270011. | en_US |
dc.identifier.uri | https://bura.brunel.ac.uk/handle/2438/23904 | - |
dc.description.abstract | Copyright © 2022 The Author(s) and Wiley-VCH GmbH. Biomicrofluidic Models Biomicrofluidic models allow nanoparticle-cellular interactions to be studied under physiological flow conditions. Investigating nanoparticle biophysicochemical properties in models that resemble disease can provide valuable information about the nano-bio interface. By screening nanoparticles dynamically against a developed dysfunctional-endothelium-on chip model, Nazila Kamaly and co-workers show in article number 2100092 that nanoparticle size is a dominant factor beyond targeting ligands. Furthermore, tight junction disruption can be restored by the inflammation resolving mediator Annexin A1. | en_US |
dc.description.uri | https://onlinelibrary.wiley.com/doi/10.1002/anbr.202270011 | - |
dc.format | Cover picture | - |
dc.format.medium | Electronic | - |
dc.language.iso | en_US | en_US |
dc.publisher | Wiley-VCH GmbH | en_US |
dc.rights | © 2022 Wiley-VCH GmbH [and the Author(s)]. This is an open access article [cover picture and abstract] under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | - |
dc.title | A Biomicrofluidic Screening Platform for Dysfunctional Endothelium-Targeted Nanoparticles and Therapeutics | en_US |
dc.type | Image | en_US |
dc.identifier.doi | https://doi.org/10.1002/anbr.202270011 | - |
dc.identifier.eissn | 2699-9307 | - |
Appears in Collections: | Dept of Life Sciences Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Cover-Picturel.pdf | 26.97 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License